financetom
Business
financetom
/
Business
/
US Box Office Set to Rebound in Fourth Quarter, B. Riley Says
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
US Box Office Set to Rebound in Fourth Quarter, B. Riley Says
Oct 20, 2025 9:33 AM

12:06 PM EDT, 10/20/2025 (MT Newswires) -- US box office is poised for a rebound in the final quarter of 2025 after the lack of a blockbuster movie drove a disappointing third quarter, B. Riley Securities said in a note e-mailed Monday.

The brokerage said it is now projecting fourth-quarter domestic box office collections of $2.59 billion, about $10 million lower than its prior estimate and $100 million below consensus, but still indicating double-digit annual growth. It estimates third-quarter domestic ticket sales to have dropped 11% year over year to $2.37 billion.

The fourth-quarter projection takes into account a weaker start for Walt Disney's ( DIS ) "Tron: Ares" science fiction action film released earlier this month and a "solid line-up" for November, B. Riley analyst Drew Crum wrote in the note. The outlook also factors in expectations that the December release of the "Avatar: Fire and Ash" movie will underpin a strong finish to the year.

Still, the brokerage tempered its estimates for this year and the next.

Crum estimates total domestic ticket sales to grow 6% year over year to $9.06 billion in 2025, down from his prior forecast of $9.07 billion.

For next year, the brokerage is projecting $9.55 billion in box office proceeds, implying 5% growth but a downgrade from its previous estimate of $9.69 billion. The outlook reflects "a limited calendar for (the first quarter), a tough April-May comp, and potential slate congestion in December with 'Avengers: Doomsday' and 'Dune: Part Three' both releasing on the same day," Crum said.

Imax ( IMAX ) and Marcus (MCS) are still B. Riley's "top picks" among five movie theater stocks that it covers, both with a buy recommendation. The brokerage has a neutral rating on AMC Entertainment ( AMC ) , Cinemark (CNK) and National CineMedia ( NCMI ) .

Price: 2.74, Change: -0.01, Percent Change: -0.18

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Up 14%, PPX Mining subscribes US$2.5 Million Silver Royalty LOI
Up 14%, PPX Mining subscribes US$2.5 Million Silver Royalty LOI
Mar 12, 2024
01:28 PM EDT, 03/12/2024 (MT Newswires) -- Up 14%, PPX Mining Corp. ( SNNGF ) announced Tuesday that it has subscribed a letter of intent (LOI) with Silver Crown Royalties Inc. (SCR) for a silver royalty to complete project financing for the 350 tpd CIL and flotation plant that the company intends to build. The plant will process oxide and...
Visa, Taulia Partner to Help Businesses Access Embedded Finance
Visa, Taulia Partner to Help Businesses Access Embedded Finance
Mar 12, 2024
01:28 PM EDT, 03/12/2024 (MT Newswires) -- Visa (V) and SAP (SAP) company Taulia said Tuesday they entered into a partnership to help businesses worldwide access embedded finance. The companies said the collaboration will make virtual payment credentials work natively across SAP business applications to simplify business-to-business payments. They said Visa's digital payments technology will be incorporated into Taulia Virtual...
Rocket Lab Sends Another Satellite Using Reusable Rocket
Rocket Lab Sends Another Satellite Using Reusable Rocket
Mar 12, 2024
01:28 PM EDT, 03/12/2024 (MT Newswires) -- Rocket Lab USA ( RKLB ) on Tuesday said it successfully sent a satellite called StriX-3 into orbit using its reusable Electron rocket. The launch was commissioned by the company's longtime partner Synspective. Price: 4.35, Change: -0.14, Percent Change: -3.01 ...
Fractyl Health Reports 'Promising' Preclinical Findings From Rejuva Platform; Shares Fall
Fractyl Health Reports 'Promising' Preclinical Findings From Rejuva Platform; Shares Fall
Mar 12, 2024
01:31 PM EDT, 03/12/2024 (MT Newswires) -- Fractyl Health ( GUTS ) said Tuesday new preclinical findings for its first clinical candidate, RJVA-001, in its Rejuva pancreatic gene therapy platform showed promising results. The data provided glucose lowering and weight loss potency from pancreas-produced native human GLP-1, highlighting the capacity of pancreatic GLP-1 to provide metabolic control, the company said....
Copyright 2023-2026 - www.financetom.com All Rights Reserved